Selected Publications

The Haase lab studies hypoxia responses in physiology and pathophysiology. This page provides links to recent original publications and review articles on HIF signaling in the kidney, HIF prolyl-hydroxylase domain oxygen sensors, kidney injury, erythropoietin regulation, renal anemia and iron metabolism, pulmonary hypertension and PHD inhibitors in clinical trials.

2025-05-10T07:42:59-05:00

Carty, Bessho et al., JCI Insight. 2024

Oxidative phosphorylation in kidney collecting duct is dispensable for maintaining water homeostasis at baseline, but necessary for maximal stimulation of AQP2 expression and urinary concentration.

2024-10-01T10:35:18-05:00

Guan et al., Kidney Int. 2022

Disruption of mitochondrial complex III in cap mesenchyme but not in ureteric progenitors results in defective nephrogenesis associated with amino acid deficiency.

2024-05-01T16:18:51-05:00

Burmakin et al., Acta Physiologica. 2021

The studies provide mechanistic insights into dose-dependent effects of short-term pharmacologic HIF activation on renal hemodynamics, glomerular filtration and O2 metabolism and identify NO as a major mediator of these effects.

2024-05-01T16:17:31-05:00

Haase VH, Kidney Int Supplements. 2021

This review summarizes clinical data from global HIF-PHI trials in patients with anemia of CKD, discusses mechanisms of action and pharmacologic properties of HIF-PHIs, and deliberates over safety concerns and potential impact on anemia management in patients with CKD.

2024-10-01T10:32:33-05:00

Ishii et al., Kidney Int. 2020

Kidney epithelial targeted mitochondrial transcription factor A deficiency results in progressive mitochondrial depletion associated with severe cystic disease.